← Open Payments lookup

LINDSAY KAUFMAN: Open Payments

NPI 1225502859 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$164 in 9 payments from 8 companies in 2025. Trend: 2023 $692 · 2024 $1,040 · 2025 $164

Food & beverage: $164
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$39
Novo Nordisk Inc1$24
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$20
Bayer Healthcare Pharmaceuticals Inc.1$19
Regeneron Healthcare Solutions, Inc.1$18
Edwards Lifesciences Corporation1$17
Alnylam Pharmaceuticals Inc.1$15
Merck Sharp & Dohme LLC1$14

Products named: FARXIGA, Ozempic, LifeVest, Kerendia, EVKEEZA, SAPIEN 3 Ultra RESILIA, ONPATTRO, VERQUVO.

Industry payments across IN — which companies pay providers there.